|Table of Contents|

Clinical characteristics of patients with cord blood hematopoietic stem cell transplantation complicated with coronavirus disease 2019

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 08
Page:
1462-1464
Research Field:
Publishing date:

Info

Title:
Clinical characteristics of patients with cord blood hematopoietic stem cell transplantation complicated with coronavirus disease 2019
Author(s):
WU Chao; ZHOU Cheng; ZHOU Ming
Department of Hematology,Hunan Provincial People's Hospital,the First Affiliated Hospital of Hunan Normal University,Hunan Changsha 410005,China.
Keywords:
cord blood stem cell transplantation; COVID-19; stem cell implantation; short tandem repeat
PACS:
R733
DOI:
10.3969/j.issn.1672-4992.2024.08.016
Abstract:
Objective:To explore the clinical characteristics and treatment strategies of cord blood hematopoietic stem cell transplantation patients with coronavirus disease 2019（COVID-19）,so as to improve the clinical treatment level of such patients.Methods:The general situation,clinical diagnosis,characteristics of coronavirus disease 2019,cell viability time,treatment and prognosis of 16 patients with cord blood transplantation were retrospectively analyzed.Results:15 patients had fever with cough as the first symptom.All of them were mild patients and 1 case was medium patient.In 14 patients,hematopoietic stem cells were successfully transplanted and removed from the warehouse,1 patient had secondary implantation failure but bridge sib allogeneic hematopoietic stem cell transplantation,and 1 patient died.Conclusion:Coronavirus disease 2019 has increased the difficulty of cord blood stem cell transplantation,but more clinical data are needed to further support it.

References:

［1］ SUN G,TANG B,SONG K,et al.Unrelated cord blood transplantation vs HLA-matched sibling transplantation for adults with B-cell acute lymphoblastic leukemia in complete remission:superior OS for patients with long-term survival［J］.Stem Cell Research & Therapy,2022,13(1):500.
［2］ KAWAHARA Y,MORIMOTO A,INAGAKI J,et al.Unrelated cord blood transplantation with myeloablative conditioning for pediatric acute lymphoblastic leukemia in remission:prognostic factors［J］.Bone Marrow Transplantation,2021,56(2):1-11.
［3］ OKOEV G,WEISDORF DJ,WAGNER JE,et al.Outcomes of Chronic Graft-Versus-Host Disease (cGVHD) Following Matched Sibling Donor (MSD) Versus Umbilical Cord Blood Transplant (UCBT)［J］.Blood,2019,134(Supplement_1):2009-2009.
［4］BLANCHE P ALTER.Bone marrow failure syndromes［J］.The Japanese Journal of Pediatric Hematology,1991,5(2):137-144.
［5］ The Subspecialty Group of Gastroenterology,the Society of Pediatrics,Chinese Medical Association.Prevention and control program on 2019 novel coronavirus infection in children′s digestive endoscopy center［J］.Chinese Journal of Pediatrics,2020,58(03):175-178.
［6］ ZHAO W,GANDHI N,AFFAS S,et al.Predicting QT interval prolongation in patients diagnosed with the 2019 novel coronavirus infection［J/OL］.Annals of Noninvasive Electrocardiology,2021,26(5):e12853［2021-09-01］.https://doi.org/10.1111/anec.12853.
［7］ VESELOVA EI,RUSSKIKH AE,KAMINSKIY GD,et al.Novel coronavirus infection［J］.Tuberculosis and Lung Diseases,2020,98(4):6-14.
［8］MARTINEZ C,AGUAYO-HIRALDO P,CHAIMOWITZ N,et al.Cord blood transplantation for nonmalignant disorders:early functional immunity and high survival［J］.Blood Advances,2023,7(9):1823-1830.
［9］ KONUMA T,KANDA J,UCHIDA N,et al.Intensified conditioning regimens improved disease-free survival and engraftment after unrelated single-unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation［J］.Hematological Oncology,2022,41(1):147-158.
［10］ MA X,DEPEI W,SUN A.The use of double-unit umbilical cord blood transplantation in adults with hematologic disease［J］.Blood,2010,116(21):4579-4579.
［11］ SHINSUKE T,YASUNORI O,NAOYUKI U,et al.Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis［J］.Blood,2010,116(4):649-652.
［12］RAMIRE Z,PABLO A,WAGNE R,et al.Kinetics of chimerism and unit predominance after double umbilical cord blood transplantation［J］.Blood,2010,116(21):225.
［13］HIRABAYASHI S,KONDO T,NISHIWAKI S,et al.Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph+ ALL:A retrospective nationwide study［J］.American J Hematol,2023,98(10):1606-1618.
［14］ KUNTE S,RYBICKI L,VISWABANDYA A,et al.Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis:a multicenter study［J］.Leukemia,2022,36(3):856-864.
［15］ BENCHEVA G,GARTCHEVA L,MICHOVA A,et al.Computer modeling of the immune system reconstruction after peripheral blood stem cell transplantation［J］.Springer-Verlag,2011,7125(1):207-214.
［16］ SOLH M,BRUNSTEIN C,MORGAN S,et al.Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants［J］.Biology of Blood and Marrow Transplantation,2011,17(5):710-716.

Memo

Memo:
湖南省社会发展重点研发项目（编号：2019SK2091）；青年博士基金项目暨2023年度国家自然科学基金培育项目（编号：BSJJ202205）
Last Update: 1900-01-01